Terms: = Ovarian cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Diagnosis
12 results:
1. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/stat3 signaling.
Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
[TBL] [Abstract] [Full Text] [Related]
2. Characterization and clinical significance of the CADM1/HER2/stat3 axis in serous ovarian tumors.
Wu D; Lei Y; Liu Q; Hu H; Li H; Xie L; Zhou J
Medicine (Baltimore); 2021 Feb; 100(8):e23777. PubMed ID: 33663040
[TBL] [Abstract] [Full Text] [Related]
3. Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers.
Alizadeh A; Jebelli A; Baradaran B; Amini M; Oroojalian F; Hashemzaei M; Mokhtarzadeh A; Hamblin MR
Gene; 2021 Feb; 769():145224. PubMed ID: 33059027
[TBL] [Abstract] [Full Text] [Related]
4. Long non-coding RNA THOR promotes ovarian cancer cells progression via IL-6/stat3 pathway.
Ge J; Han T; Shan L; Na J; Li Y; Wang J
J Ovarian Res; 2020 Jun; 13(1):72. PubMed ID: 32552789
[TBL] [Abstract] [Full Text] [Related]
5. Upregulated CXCL14 is associated with poor survival outcomes and promotes ovarian cancer cells proliferation.
Li X; Zhao L; Meng T
Cell Biochem Funct; 2020 Jul; 38(5):613-620. PubMed ID: 32077118
[TBL] [Abstract] [Full Text] [Related]
6. Circulating miRNA Profiling in Plasma Samples of ovarian cancer Patients.
Penyige A; Márton É; Soltész B; Szilágyi-Bónizs M; Póka R; Lukács J; Széles L; Nagy B
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540229
[TBL] [Abstract] [Full Text] [Related]
7. Multifunctional APJ Pathway Promotes ovarian cancer Progression and Metastasis.
Neelakantan D; Dogra S; Devapatla B; Jaiprasart P; Mukashyaka MC; Janknecht R; Dwivedi SKD; Bhattacharya R; Husain S; Ding K; Woo S
Mol Cancer Res; 2019 Jun; 17(6):1378-1390. PubMed ID: 30858172
[TBL] [Abstract] [Full Text] [Related]
8. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
Ruan L; Xie Y; Liu F; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
[TBL] [Abstract] [Full Text] [Related]
9. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.
Cao Y; Shi H; Ren F; Jia Y; Zhang R
Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469
[TBL] [Abstract] [Full Text] [Related]
10. Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.
Corno C; Gatti L; Arrighetti N; Carenini N; Zaffaroni N; Lanzi C; Perego P
Biochem Pharmacol; 2017 Jul; 136():40-50. PubMed ID: 28404378
[TBL] [Abstract] [Full Text] [Related]
11. Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer.
Nakamura H; Nagasaka K; Kawana K; Taguchi A; Uehara Y; Yoshida M; Sato M; Nishida H; Fujimoto A; Inoue T; Adachi K; Nagamatsu T; Arimoto T; Oda K; Osuga Y; Fujii T
BMC Cancer; 2016 Nov; 16(1):897. PubMed ID: 27855669
[TBL] [Abstract] [Full Text] [Related]
12. Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours.
Chu PG; Lyda MH; Weiss LM
Histopathology; 2001 Jul; 39(1):9-16. PubMed ID: 11454039
[TBL] [Abstract] [Full Text] [Related]
